Company profile
Grace Therapeutics, Inc. Insider Trading
GRCEEvery SEC Form 4 insider trading filing for Grace Therapeutics, Inc. (GRCE) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001444192
- Filings
- 46
- Insiders
- 12
- Last filing
- 2026-09-23
Activity summary
Recent insider activity is bullish. Over the last 30 days, 5 insiders purchased shares (net $278K). Buying was led by Prashant Kohli.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Grace Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $302K.
90 day insight
Over the last 90 days, Grace Therapeutics, Inc. insiders bought $302K across 6 transactions with no open-market sales.
- Most active insider: Opaleye Management Inc. with 5 transactions totaling $88K.
- Largest single purchase: $214K by Prashant Kohli on Sep 9, 2026.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Opaleye Management Inc. | GRCE | Purchase | 5,318 | $2.10 | $11K |
| Sep 21, 2026 | Opaleye Management Inc. | GRCE | Purchase | 9,771 | $2.10 | $21K |
| Sep 17, 2026 | George Kottayil | GRCE | Award | 12,200 | — | — |
| Sep 17, 2026 | Vimal Kavuru | GRCE | Award | 12,200 | — | — |
| Sep 17, 2026 | A Brian Davis | GRCE | Award | 0 | — | — |
42 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=GRCE" \
-H "X-Api-Key: $KEY"Top insiders
By open-market value traded.
Institutional Ownership
Top 13F-HR holders of Grace Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →